These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32638165)

  • 21. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?
    Deng HY; Zhou J; Wang RL; Jiang R; Zhu DX; Tang XJ; Zhou Q
    Ann Surg Oncol; 2020 Feb; 27(2):472-480. PubMed ID: 31617120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of 206 station lymph node in transverse colon cancer.
    Xu YX; Huang Y; Wang XJ; Ye DX; Chi P
    Cancer Med; 2022 Jun; 11(12):2366-2376. PubMed ID: 35437894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study.
    Zhai W; Zheng Y; Rong Y; Li X; Yan Q; Duan F; Zhao Z; Chen J; Dai S; Wang J
    J Thorac Dis; 2021 Apr; 13(4):2184-2193. PubMed ID: 34012569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.
    Sun Y; Zhang Q; Wang Z; Shao F
    Thorac Cancer; 2021 May; 12(10):1589-1597. PubMed ID: 33793088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postoperative survival analysis of patients with stage Ⅲ-pN2 non-small cell lung cancer].
    Wu XW; Chen T; Yin S; Deng Y; Zhao B
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):782-786. PubMed ID: 30392344
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of skip N2 lymph node metastasis for patients with the stage III-N2 lung adenocarcinoma: a propensity score matching analysis.
    Wang S; Xie S; Han Y; Gao M; Su X; Liu Q
    BMC Pulm Med; 2023 Apr; 23(1):147. PubMed ID: 37118722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors after surgical resection of N1 non-small cell lung cancer.
    Mordant P; Pricopi C; Legras A; Arame A; Foucault C; Dujon A; Le Pimpec-Barthes F; Riquet M
    Eur J Surg Oncol; 2015 May; 41(5):696-701. PubMed ID: 25454825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
    Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
    J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
    Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
    J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
    Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
    Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
    Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of the extent of lymph node dissection for stage IA non-small-cell lung cancer on patient disease-free survival.
    Xu F; Qi L; Yue D; Wang C
    Clin Lung Cancer; 2013 Mar; 14(2):181-7. PubMed ID: 23195117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.